Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enough is a food biotechnology company that specializes in the high-efficiency production of sustainable protein through fungal fermentation. The company's core product, ABUNDA mycoprotein, is a complete protein source containing all essential amino acids and high fiber content, produced with significantly lower environmental impact than animal-based proteins. Enough utilizes a unique zero-waste fermentation process, often co-locating with grain processors to use starch side-streams as feedstock. The company operates a large-scale manufacturing facility in Sas van Gent, Netherlands, which is one of the largest of its kind globally. By partnering with major food retailers and manufacturers, Enough aims to provide a scalable solution to the global demand for sustainable nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enough.